Related references
Note: Only part of the references are listed.Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study
Toshihiko Oshita et al.
CLINICA CHIMICA ACTA (2020)
Assessment of HDL Cholesterol Removal Capacity: Toward Clinical Application
Ryuji Toh
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Impaired Cholesterol-Uptake Capacity of HDL Might Promote Target-Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation
Yuichiro Nagano et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia
Kyong Yeun Jung et al.
CIRCULATION JOURNAL (2018)
Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment
Amane Harada et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2017)
Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation
Satoshi Imaizumi et al.
HEART AND VESSELS (2016)
Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study
Chaoqun Liu et al.
ATHEROSCLEROSIS (2016)
Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease
Yoko Haraguchi et al.
ATHEROSCLEROSIS (2014)
High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease
Akintunde O. Akinkuolie et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients
Maki Miyamoto-Sasaki et al.
Journal of Atherosclerosis and Thrombosis (2013)
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
Andrew J. Murphy et al.
NATURE MEDICINE (2013)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PredictABEL: an R package for the assessment of risk prediction models
Suman Kundu et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol
Xuewei Zhu et al.
JOURNAL OF LIPID RESEARCH (2010)
Increased Inflammatory Gene Expression in ABC Transporter-Deficient Macrophages Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions
Laurent Yvan-Charvet et al.
CIRCULATION (2008)
Beyond high-density lipoprotein cholesterol levels - Evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
Emil M. deGoma et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation
RE Moore et al.
CIRCULATION RESEARCH (2005)
Share Paper
